Generation Bio Co

Call
Website
301 Binney St Ste 3
Cambridge, MA 02142
+1 (617) 655-7500
https://generationbio.com

Generation Bio Co, based in Cambridge, MA, is pioneering advancements in targeted therapeutics for T cell-driven autoimmune diseases through its innovative cell-targeted lipid nanoparticles (ctLNP) technology. This approach enables selective delivery of siRNA specifically to T cells, effectively modulating their function while preserving the integrity of the broader immune system.

The company's mission is to unlock the full potential of siRNA therapeutics in T cells, aiming to create more potent and better-tolerated treatments for autoimmune conditions. With a dedicated and experienced team, Generation Bio is set to lead the next wave of targeted siRNA therapeutics, providing novel solutions for patients living with these challenging diseases.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs acting on the respiratory system, Drugs affecting neoplasms and endrocrine systems

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a biotechnology company based in Cambridge, MA, specializing in the research and development of innovative therapies for various medical conditions. The company focuses on utilizing cutting-edge technology and scientific expertise to create novel treatments that aim to improve patient outcomes and address unmet medical needs. Generated from their business information
Drugs acting on the respiratory system, Sizes

Casma Therapeutics Inc

Arkuda is comprised of passionate and experienced team members who are dedicated to improving the lives of people affected by neurodegenerative disease. Armed with deep expertise in biology and the ab
Business services, nec, nec, Drugs acting on the respiratory system, Blood derivatives

Orbital Therapeutics

Orbital Therapeutics, based in Cambridge, MA, is dedicated to advancing RNA medicines aimed at expanding access to innovative therapies for patients with various diseases. Their cutting-edge platform integrates RNA discovery and design, focusing on immune reprogramming to help restore health by delivering precise molecular instructions directly to immune cells. The company emphasizes a culture of collaboration and has assembled a team experienced in transitioning medicines from concept to clinical application. Through their comprehensive RNA platform, Orbital Therapeutics seeks to engineer durable therapies with the flexibility needed to effectively modulate disease outcomes. Generated from the website
United States›Massachusetts›Cambridge›Generation Bio Co

Partial Data by Infogroup (c) 2025. All rights reserved.